What is Allurion?
Allurion offers a comprehensive weight-loss program that integrates advanced technology with personalized care. The Allurion Program features the world's first swallowable, procedureless gastric balloon, the Allurion Smart Capsule, designed for effective weight management. Complementing this is the Allurion Virtual Care Suite, which includes a mobile app for consumers and a provider-facing platform, Allurion Insights, powered by the Iris AI Platform. This integrated approach aims to provide a seamless and supportive experience for individuals seeking to achieve and maintain a healthy weight. The company's technology is also available to healthcare providers independently, enabling customized patient management regardless of their specific treatment plan. The Allurion Smart Capsule is currently an investigational device in the United States.
How much funding has Allurion raised?
Allurion has raised a total of $281.3M across 16 funding rounds:
Private Equity
$6M
Multiple Rounds
$52M
Series B
$34M
Debt
$1M
Debt
$1M
Debt
$25M
Stock Offering
$100M
Debt
$48M
Share Placement
$2.3M
Stock/Share Issuance
$5M
Private Equity (2016): $6M backed by Romulus Capital
Private Equity (2017): $19M, investors not publicly disclosed
Series C (2017): $27M led by Romulus Capital and IDO Investments
Debt (2017): $6M supported by Silicon Valley Bank
Series B (2020): $34M featuring Romulus Capital, Novalis LifeSciences, Bridge Bank, and IDO Investments
Debt (2020): $1M backed by PPP
Debt (2021): $1M with participation from PPP
Debt (2021): $25M led by Runway Growth Capital LLC
Stock Issuance/Offering (2023): $100M, investors not publicly disclosed
Debt (2024): $48M featuring RTW Investments
Share Placement (2024): $2.3M, investors not publicly disclosed
Stock/Share Issuance (2025): $5M, investors not publicly disclosed
Key Investors in Allurion
Romulus Capital
Romulus Capital is an early-stage venture capital firm founded in 2008, focusing on leading Seed and Series A rounds for B2B companies that disrupt traditional industries or are deep technology firms emerging from elite research groups. The firm operates primarily in major cities such as Boston, San Francisco, Los Angeles, New York, and Dallas. Their hands-on approach is driven by their origins as a scrappy startup, maintaining a hunger for innovative technology investments. Romulus Capital aims to build great companies through strategic funding and support.
IDO Investments
IDO Investments is a technology investment firm based in Oman, focused on accelerating the growth of a knowledge-based economy. The company invests in established growth-stage startups that offer disruptive and innovative products or solutions on a global scale. They aim to identify promising opportunities and actively contribute to the success of their portfolio companies. Their investments span various sectors, including healthcare, cybersecurity, and digital solutions.
RTW Investments
RTW is a life sciences investment and innovation firm that focuses on biotech and medtech innovation throughout the entire lifecycle, from company creation to public companies. The firm partners with companies at various stages of development, providing not just capital but also expertise to support their success. RTW aims to identify and develop transformative companies that significantly improve patients' lives, leveraging deep scientific knowledge and a long-term investment approach. Their mission extends beyond financial gain, as they strive to create a greater impact in science and medicine for the benefit of patients worldwide.
What's next for Allurion?
With the recent major strategic investment and substantial overall capital secured, Allurion is poised for significant advancements. The company's focus on a procedureless gastric balloon and a comprehensive virtual care suite positions it for strong growth in the expanding digital health and weight management markets. Future developments are likely to involve further enhancement of its AI-driven insights, broader market penetration, and continued innovation in its product offerings. The substantial backing suggests a strategic push towards scaling operations and solidifying its market leadership in innovative weight-loss solutions.
See full Allurion company page
